Neogen Corporation Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
Neogen Corporation (NEOG) had Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued of $800.00 thousand as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued · last filed 2026-07-30
- 2026-05-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $800.00K.
- 2025-05-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $400.00K; Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued as first filed $385.00K.
- 2024-05-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $200.00K; Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued as first filed $246.00K.
- 2023-05-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $145.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued as first filed |
|---|---|---|
| 2026-05-31 | $800.00K 10-K · filed 2026-07-30 | |
| 2025-05-31 | $400.00K 10-K · filed 2026-07-30 | $385.00K 10-K · filed 2025-07-30 |
| 2024-05-31 | $200.00K 10-K · filed 2026-07-30 | $246.00K 10-K · filed 2024-07-30 |
| 2023-05-31 | $145.00K 10-K · filed 2025-07-30 | |
| 2022-05-31 | $69.00K 10-K · filed 2024-07-30 | $69.32K 10-K · filed 2022-07-27 |
| 2021-05-31 | $65.00K 10-K · filed 2023-08-15 | $64.52K 10-K · filed 2022-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |